Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-07

FDA Approved: RANITIDINE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ranitidine submitted by Rising Pharma Holdings, Inc., indicating an approved change to the previously authorized…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranitidine (Ranitidine)

Snippet

SUPPL AP for RANITIDINE (RANITIDINE)